Autism Treatment Study Underway VANCOUVER, BC, Feb. 9, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company“)is pleased to announce that its proprietary drug psilocybin has been shipped to the laboratory of Dr. Viviana Trezza, Roma Tre University, Rome, Italy. NOVA was notified by its U.S. drug manufacturer that the required controlled…

Source

Previous articleNew Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate
Next articleFeb 10: $SPOR +40.91%, $PSYC +35.42%, $MCUR +23.33%